Mangoceuticals (NASDAQ:MGRX) Issues Earnings Results

Mangoceuticals (NASDAQ:MGRX) issued its quarterly earnings data on Thursday. The company reported ($1.01) earnings per share (EPS) for the quarter, Zacks reports. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%.

Mangoceuticals Stock Performance

MGRX stock traded up $0.08 during midday trading on Thursday, reaching $4.35. 65,411 shares of the company traded hands, compared to its average volume of 225,913. Mangoceuticals has a 52-week low of $2.07 and a 52-week high of $16.80. The business has a 50 day moving average of $3.75 and a 200-day moving average of $14.74. The firm has a market capitalization of $10.82 million, a price-to-earnings ratio of -0.75 and a beta of 1.51.

Mangoceuticals Company Profile

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.